Advanced cancer care, within reach.

Expanding access to advanced cancer care across borders.

We help healthcare providers and pharmaceutical companies navigate international markets, reimbursement, and patient access—while developing AI-enabled tools to help patients explore treatment options abroad.

How we help

Two complementary approaches to improving access to advanced cancer care.

For healthcare organizations

International Market Access & Growth Advisory

We help healthcare providers and pharmaceutical companies evaluate international opportunities, navigate reimbursement and patient access barriers, and develop evidence-based expansion strategies.

Market & Regulatory Landscape

Assess healthcare systems, regulatory requirements, referral pathways, and competitive dynamics.

Reimbursement & Payer Analysis

Evaluate coverage policies, payment mechanisms, and patient affordability.

Market Opportunity Assessment

Identify unmet needs, access barriers, and opportunities for international patient access.

Market Entry Strategy

Develop actionable expansion strategies informed by market evidence and financial analysis.

Discuss your expansion plans

Our expertise

Experience across healthcare markets

Our leadership brings experience in health insurance, strategic finance, and international healthcare markets, including work spanning more than 20 markets across the US, Europe, and Asia.

Our initial focus

Advanced cancer treatment access

We begin with oncology, where differences in treatment availability, reimbursement, and affordability can limit access.

Areas of interest: CAR-T cell therapy, proton therapy, and other emerging cell and gene therapies.

Contact

Let's explore opportunities together.

Whether you're evaluating international market expansion or interested in our developing patient navigation technology, we'd welcome a conversation.

Contact Sunderise

Tell us a little about your organization and what you would like to discuss.